1st Quarter - Amendment

AMERICAN OSTEOPATHIC ASSOCIATION for AMERICAN OSTEOPATHIC ASSOCIATION

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$205,761
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 20, 2017 $205,761 Replaced
1st Quarter - Amendment (this page) Apr 20, 2017 $205,761 Replaced
1st Quarter - Amendment Apr 20, 2017 $205,761 Yes

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Recognition of Osteopathic Certification

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Sr. Vice President Public Policy

Contacted: Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Office of Management & Budget (OMB); Government Accountability Office (GAO); Medicare Payment Advisory Commission (MedPAC); SENATE; Agency for Healthcare Research & Quality (AHRQ); Health & Human Services, Dept of (HHS); White House Office; HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS)

Taxation/Internal Revenue Code TAX

Flexible Spending Accounts; Health Savings Accounts

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Sr. Vice President Public Policy

Contacted: Government Accountability Office (GAO); Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); Executive Office of the President (EOP); White House Office; Office of Management & Budget (OMB); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC)

Medical/Disease Research/Clinical Labs MED

NIH; FDA; Agency for Health Care Quality & Research Funding

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Sr. Vice President Public Policy

Contacted: White House Office; Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Government Accountability Office (GAO); Centers For Disease Control & Prevention (CDC); SENATE; Executive Office of the President (EOP); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Agency for Healthcare Research & Quality (AHRQ)

Torts TOR

Professional Liability Insurance; Medical Liability Reform

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Sr. Vice President Public Policy

Contacted: Agency for Healthcare Research & Quality (AHRQ); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB); Government Accountability Office (GAO); Health & Human Services, Dept of (HHS); White House Office; Medicare Payment Advisory Commission (MedPAC)

Budget/Appropriations BUD

Labor HHS Appropriations

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Sr. Vice President Public Policy

Contacted: Agency for Healthcare Research & Quality (AHRQ); Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); Government Accountability Office (GAO); Food & Drug Administration (FDA); SENATE; White House Office; Executive Office of the President (EOP); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Education EDU

Student Loan Financing and Re-Financing

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Sr. Vice President Public Policy

Contacted: Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Agency for Healthcare Research & Quality (AHRQ); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); SENATE; White House Office; Office of Management & Budget (OMB); Government Accountability Office (GAO); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Medicare Payment Advisory Commission (MedPAC)

Health Issues HCR

U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), White House Office, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), Office of Management & Budget (OMB), Executive Office of the President (EOP)

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Sr. Vice President Public Policy

Contacted: Agency for Healthcare Research & Quality (AHRQ); Government Accountability Office (GAO); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); SENATE; White House Office; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA)

Medicare/Medicaid MMM

Graduate Medical Education; Health Care Quality, Patient Access to Health Care; Physician Workforce; Medicare Physician Payment Issues; Independent Payment Advisory Board. H.R. 574, The Medicare Physician Payment Innovation Act of 2013.

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Sr. Vice President Public Policy

Contacted: Office of Management & Budget (OMB); Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); White House Office; Medicare Payment Advisory Commission (MedPAC); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); SENATE; Health & Human Services, Dept of (HHS); Government Accountability Office (GAO)

Bills named: H.R. 574 (115th)

Insurance INS

Health Insurance; Professional Liability Insurance; State Insurance Marketplace

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Sr. Vice President Public Policy

Contacted: HOUSE OF REPRESENTATIVES; Government Accountability Office (GAO); SENATE; Office of Management & Budget (OMB); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Executive Office of the President (EOP); Agency for Healthcare Research & Quality (AHRQ); White House Office; Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.